MESO FY 2017 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena

MESOMesoblast Limited

$2B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-94.3% YoY

Gross Profit

-$10M-400.2% margin

Operating Income

-$90M-3733.1% margin

Net Income

-$77M-3184.7% margin

EPS (Diluted)

$-1.40

Cash Flow

Operating Cash Flow

-$95M

Free Cash Flow

-$96M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$656M

Total Liabilities

$139M

Stockholders' Equity

$517M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$43M	-94.3%
Gross Profit	-$10M	$13M	-175.5%
Operating Income	-$90M	-$56M	-61.1%
Net Income	-$77M	-$4M	-1761.3%